Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | NT5E | P21589 | 1/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.62 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.62 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.62 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.60 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.60 |
| ▸ | DPP4 | P27487 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.60 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.60 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.60 |
| ▸ | GAPDH | P04406 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | STAT6 | P42226 | 1/20 | 0.60 |
| ▸ | PI4KA | P42356 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4725713 | 0.93 | LMNA (0.60) | LMNANT5EHIF1AADORA2AADORA3 | |
| SCHEMBL4725716 | 0.93 | LMNA (0.60) | LMNANT5EHIF1AADORA2AADORA3 | |
| SCHEMBL7030265 | 0.91 | LMNA (0.55) | LMNANT5EHIF1AADORA2AADORA3 | |
| SCHEMBL5698874 | 0.91 | LMNA (0.55) | LMNANT5EHIF1AADORA2AADORA3 | |
| SCHEMBL5033515 | 0.89 | LMNA (0.62) | LMNANT5EHIF1AADORA2AADORA3 | |
| SCHEMBL899617 | 0.89 | LMNA (0.62) | LMNANT5EHIF1AADORA2AADORA3 | |
| SCHEMBL16555404 | 0.89 | LMNA (0.62) | LMNANT5EHIF1AADORA2AADORA3 | |
| SCHEMBL2014081 | 0.89 | LMNA (0.62) | LMNANT5EHIF1AADORA2AADORA3 | |
| SCHEMBL3970946 | 0.89 | LMNA (0.62) | LMNANT5EHIF1AADORA2AADORA3 | |
| SCHEMBL62505 | 0.88 | CYP2C19 (0.62) | LMNANT5EHIF1AADORA2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9914914-B2 | Polymerase capable of producing non-DNA nucleotide polymers | MEDICAL RESEARCH COUNCIL (GB) | 2018-03-13 | — | — | US | disclosed |
| US-20150275192-A1 | POLYMERASE CAPABLE OF PRODUCING NON-DNA NUCLEOTIDE POLYMERS | UNITED KINGDOM RESEARCH AND INNOVATION (GB) | 2015-10-01 | — | — | US | disclosed |
| EP-2844665-A1 | POLYMERASE CAPABLE OF PRODUCING NON-DNA NUCLEOTIDE POLYMERS | Medical Research Council (GB) | 2015-03-11 | — | — | EP | disclosed |
| WO-2013156786-A1 | POLYMERASE CAPABLE OF PRODUCING NON-DNA NUCLEOTIDE POLYMERS. | MEDICAL RESEARCH COUNCIL (GB) | 2013-10-24 | — | — | WO | disclosed |
| WO-2004012745-A1 | ANTISENSE MODULATION OF PERILIPIN EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2004-02-12 | — | — | WO | disclosed |
| WO-2004005312-A1 | ANTISENSE MODULATION OF PTPRK EXPRESSION | ISIS PHARMACEUTICALS INC. (US) | 2004-01-15 | — | — | WO | disclosed |
| WO-2003102242-A1 | NOTCH 1 INHIBITORS FOR INDUCING APOPOTOSIS | ISIS PHARMACEUTICALS, INC. (US) | 2003-12-11 | — | — | WO | disclosed |
| EP-1343913-A2 | ANTISENSE MODULATION OF SRC-2 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2003-09-17 | — | — | EP | disclosed |
| EP-1328537-A1 | ANTISENSE MODULATION OF BH3 INTERACTING DOMAIN DEATH AGONIST EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2003-07-23 | — | — | EP | disclosed |
| EP-1030935-A4 | ANTISENSE OLIGONUCLEOTIDE MODULATION OF HUMAN SERINE/THREONINE PROTEIN PHOSPHATASE GENE EXPRESSION | UNIV SOUTH ALABAMA (US) | 2003-05-21 | — | — | EP | disclosed |
| WO-2002061132-A1 | ANTISENSE MODULATION OF CHK2 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2002-08-08 | — | — | WO | disclosed |
| WO-2002046367-A2 | ANTISENSE MODULATION OF CELLULAR APOPTOSIS SUSCEPTIBILITY GENE EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2002-06-13 | — | — | WO | disclosed |
| WO-2002042423-A2 | ANTISENSE MODULATION OF SRC-2 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2002-05-30 | — | — | WO | disclosed |
| WO-2002036810-A2 | ANTISENSE MODULATION OF TALIN EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2002-05-10 | — | — | WO | disclosed |
| WO-2002020547-A1 | ANTISENSE MODULATION OF BH3 INTERACTING DOMAIN DEATH AGONIST EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2002-03-14 | — | — | WO | disclosed |
| EP-1135402-A1 | ANTISENSE MODULATION OF EGR-1 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2001-09-26 | — | — | EP | disclosed |
| EP-1030935-A1 | ANTISENSE OLIGONUCLEOTIDE MODULATION OF HUMAN SERINE/THREONINE PROTEIN PHOSPHATASE GENE EXPRESSION | South Alabama Medical Science Foundation (US) | 2000-08-30 | — | — | EP | disclosed |
| WO-2000035935-A1 | ANTISENSE MODULATION OF CD44 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2000-06-22 | — | — | WO | disclosed |
| WO-2000034302-A1 | ANTISENSE MODULATION OF EGR-1 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2000-06-15 | — | — | WO | disclosed |
| WO-1999027134-A1 | ANTISENSE OLIGONUCLEOTIDE MODULATION OF HUMAN SERINE/THREONINE PROTEIN PHOSPHATASE GENE EXPRESSION | SOUTH ALABAMA MEDICAL SCIENCE FOUNDATION (US) | 1999-06-03 | — | — | WO | disclosed |